http://server.ccl.net/cca/info/conferencelist/mess0030669.shtml |
CCL 21.06.22 Webinar - New Approaches in GPCR Drug Design - June 22 (4PM - CET/10AM - EDT) | |
From: chemistry-request at ccl.net To: chemistry-request at ccl.net Date: Tue Jun 8 09:50:29 2021 Subject: 21.06.22 Webinar - New Approaches in GPCR Drug Design - June 22 (4PM - CET/10AM - EDT) With around 35% of approved drugs targeting 108 members of GPCRs, this protein family is probably one of the most interesting and challenging targets when designing new drugs that modulate the downstream processes regulated by these proteins. This new session of PharmWebinars intends to show which are the current challenges and state-of-the-art computational approaches in this area. We have invited three excellent speakers to share how they face the design of new drugs against these complex systems and the challenges they encounter. As usual, the webinar will have a Q&A session to ask and share experiences. Registration: https://attendee.gotowebinar.com/register/1113934337234961163?source=ccl Contact Email: mel(dot)berg(at)pharmacelera(dot)comNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!! All @ signs were changed to /a\ to fight spam. Before you send e-mail, you need to change /a\ to @ For example: change joe/a\big123comp.com to joe@big123comp.com Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/. Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!! |
[ CCL Home Page ]
[ Conferences ]
[ Jobs ]
[ Resumes ]
[ Raw Version of this page ]
Modified: Tue Jun 8 13:50:29 2021 GMT |
Page accessed 2115 times since Tue Jun 8 13:46:21 2021 GMT |
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.